DEA to Authorize Cultivating 3.2 million grams of Cannabis for research purposes in U.S.

The U.S. Drug Enforcement Administration (DEA) is planning to increase the amount of cannabis it authorizes for sole purposes for research use by nearly 30 percent for 2019 while authorizing the production of fewer opioids.

The federal agency published its proposed quotas back in September and after a period of public comment decided to stick with the 3.2 million g of marijuana it initially suggested, Marijuana Moment reported.

Number of recent reports suggest demand for access to high-quality cannabis is on the rise as more states legalize cannabis and look to conduct research into its potential benefits.

Source: Marijuana Moment, DEA

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Next Post

Khiron Welcomes Legalization of Medical Cannabis in Brazil

With a population of over 200 million this will directly benefit the health and wellbeing of a significant number of patients in Brazil… Brazil represents the largest addressable market in Latin America with a population of 208 million and a potential USD $229 Million patient network for medical cannabis (New Frontier Data) Brazilian national health authority […]
%d bloggers like this: